# Meati

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/meati

- Industry: Food
- Headquarters: Boulder, US
- Website: www.meati.com
- Total disclosed funding: $528M
- Latest round: Series C (Apr 19, 2024)
- Investors on record: 18

## About

Emergy Inc., doing business as Meati, based in the US, specializes in creating innovative mycelium-based vegan meat alternatives, offering a variety of tasty products that cater to health-conscious consumers seeking sustainable protein options. Founded in 2017 in Boulder, Colorado, Emergy Inc., doing business as Meati Inc. focuses on developing plant-based protein products. The company was co-founded by Justin Whiteley, and Tyler Huggins.In April 2024, Meati raised USD 222.41 million in series C funding led by Grosvenor, with participation from Prelude Ventures, Bond, Revolution Ventures, and Congruent Ventures. Meati Foods specializes in mycelium-based vegan meat alternatives, offering a diverse range of products including the Classic Cutlet, Crispy Cutlet, Classic Steak, and various breakfast patties. These products are designed to provide a nutritious and sustainable protein source, catering specifically to consumers seeking plant-based options. The core offerings are aimed at health-conscious individuals and those looking to reduce their meat consumption without sacrificing flavor or texture. The mycelium used in Meati's products serves as a natural energy source, contributing to an appealing meaty texture while being environmentally sustainable. Meati Foods targets a wide geographical market, including urban areas in the United States and select international markets, appealing to both retail consumers and health-oriented establishments.Meati Foods generates revenue primarily through direct-to-consumer sales and retail partnerships. Customers can purchase products online via the company’s website, as well as through grocery and health food retailers. The company plans to use the funding from April 2024 to support the escalating demand for its plant-based protein products.

## Funding rounds

- Series C, Apr 19, 2024, $222M — Grosvenor, Revolution Ventures, Prelude Ventures, Congruent Ventures, Bond
- Series C, Sep 7, 2023, $50M — Revolution Ventures, Congruent Ventures, Bond
- Series C, Jan 26, 2023, $22M — Revolution Ventures, Rockefeller Capital Management
- Series C, Jul 21, 2022, $151M — CPP Investment Board, Grosvenor, Wellington Management, Revolution Ventures, Nextwave X Partners
- Series B, Jun 30, 2021, $50M — Prelude Ventures, Tao Capital Partners, Acre Venture Partners, Congruent Ventures, Bond
- Series A, Aug 20, 2020, $28M — Prelude Ventures, Tao Capital Partners, Congruent Ventures
- Seed, Jul 17, 2019, $1M — Social Starts
- Seed, Apr 16, 2019, $3.8M — Better Ventures, Prelude Ventures, Bluestein Ventures, Congruent Ventures, Trust Ventures, Fifty Years, The March Group, Unovis Asset Management

## Investors

- Better Ventures — Seed
- Prelude Ventures — Seed, Series A, Series B, Series C
- Bluestein Ventures (https://capitalatlas.ai/funds/bluestein-ventures) — Seed
- Congruent Ventures (https://capitalatlas.ai/funds/congruent-ventures) — Seed, Series A, Series B, Series C
- Trust Ventures (https://capitalatlas.ai/funds/trust-ventures) — Seed
- Fifty Years (https://capitalatlas.ai/funds/fifty-years) — Seed
- The March Group (https://capitalatlas.ai/funds/the-march-group) — Seed
- Unovis Asset Management (https://capitalatlas.ai/funds/unovis-asset-management) — Seed
- Social Starts (https://capitalatlas.ai/funds/social-starts) — Seed
- Tao Capital Partners (https://capitalatlas.ai/funds/tao-capital-partners) — Series A, Series B
- Acre Venture Partners (https://capitalatlas.ai/funds/acre-venture-partners) — Series B
- Bond (https://capitalatlas.ai/funds/bond) — Series B, Series C
- CPP Investment Board — Series C
- Grosvenor — Series C
- Wellington Management (https://capitalatlas.ai/funds/wellington-management) — Series C
- Revolution Ventures (https://capitalatlas.ai/funds/revolution-ventures) — Series C
- Nextwave X Partners (https://capitalatlas.ai/funds/nextwave-x-partners) — Series C
- Rockefeller Capital Management — Series C